Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
      • Doodle Gallery
      • Circulation Cover Doodle
        • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
    • Subscribe to AHA Journals
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
      • Recently Published Guidelines
    • Bridging Disciplines
    • Circulation at Major Meetings
    • Special Themed Issues
    • Global Impact of the 2017 ACC/AHA Hypertension Guidelines
    • Circulation Supplements
    • Cardiovascular Case Series
    • ECG Challenge
    • Hospitals of History
      • Brigham and Women's Hospital
      • Hartford Hospital
      • Hospital Santa Maria del Popolo, Naples, Italy
      • Instituto do Coração-INCOR (São Paulo, Brasil)
      • Minneapolis City Hospital
      • Parkland Hospital: Dallas, Texas
      • Pennsylvania Hospital, Philadelphia
      • Pitié-Salpêtrière Hospital
      • Royal Infirmary of Edinburgh, Scotland
      • Tufts Medical Center
      • University of Michigan
      • Uppsala University Hospital
      • Vassar Brothers Medical Center (Poughkeepsie, NY)
      • Wroclaw Medical University
      • Women's College Hospital, Toronto, Canada
      • Henry Ford Hospital, Detroit, Michigan
      • Instituto Nacional de Cardiología Ignacio Chávez – INCICh México City, México
      • Kuang-Tien General Hospital (Taichug, Taiwan)
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
    • →Circulation FIT Podcast 2018
    • → #FITFAVs
  • Resources
    • Instructions for Authors
      • Accepted Manuscripts
      • Revised Manuscripts
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
    • Subscribe to AHA Journals
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • Circulation at Major Meetings
    • Special Themed Issues
    • Global Impact of the 2017 ACC/AHA Hypertension Guidelines
    • Circulation Supplements
    • Cardiovascular Case Series
    • ECG Challenge
    • Hospitals of History
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
    • →Circulation FIT Podcast 2018
    • → #FITFAVs
  • Resources
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Core 6. Catheter-Based and Surgical InterventionsSession Title: Periprocedural Complications in PCI

Abstract 12514: Percutaneous Coronary Intervention is Beneficial For Better Survival Compared With Medication Alone in Chronic Hemodialysis Patients With Single-Vessel Disease

Takashi Sakakibara, Hideki Ishii, Kouhei Yoneda, Kazuhiro Kawashima, Yoshihiro Kawamura, Daisuke Kamoi, Toru Aoyama, Kyuuichi Furuhashi, Yoshitake Kumada, Hiroshi Takahashi, Miho Tanaka, Toyoaki Murohara
Circulation. 2011;124:A12514
Takashi Sakakibara
cardiovascular center, Nagoya Kyoritsu Hosp, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideki Ishii
cardiology, Nagoya Univ Graduate Sch of Medicine, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kouhei Yoneda
Cardiovascular center, Nagoya Kyoritsu Hosp, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazuhiro Kawashima
cardiovascular center, Nagoya Kyoritsu Hosp, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshihiro Kawamura
cardiovascular center, Nagoya Kyoritsu Hosp, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daisuke Kamoi
cardiovascular center, Nagoya Kyoritsu Hosp, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toru Aoyama
cardiovascular center, Nagoya Kyoritsu Hosp, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kyuuichi Furuhashi
cardiovascular center, Nagoya Kyoritsu Hosp, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshitake Kumada
cardiovascular center, Nagoya Kyoritsu Hosp, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroshi Takahashi
cardiovascular center, Nagoya Kyoritsu Hosp, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miho Tanaka
Cardiology, Nagoya Univ Graduate Sch of Medicine, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toyoaki Murohara
Cardiology, Nagoya Univ Graduate Sch of Medicine, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics

Jump to

  • Article
  • Info & Metrics
  • eLetters
Loading

Abstract

Background: Percutaneous coronary intervention (PCI) has been widely performed for coronary artery disease (CAD) even in hemodialysis (HD) patients. For single-vessel disease (SVD), PCI has been reported to improve clinical symptoms but not survival in general population, however, it remains unclear in HD patients who are regard as the highest risk group of cardiac mortality. We investigated whether PCI improves survival compared to medical therapy alone in HD patients.

Methods: Of 391 consecutive HD patients with angiographical single coronary artery stenosis, 279 patients were treated with PCI (PCI group) and 112 patients were treated with medication alone (medication group). To minimize the selection bias for PCI or medication, a propensity-matched analysis using multiple logistic regression model include male, age, diabetes, ejection fraction, left anterior descending lesion and history of cardiovascular disease was performed. Each patients in the medication group were matched with up to two patients in the PCI group PCI with two-digit propensity score (AUC = 0.63 using ROC analysis). They were followed up for up to 8 years.

Results: Baseline characteristics were comparable between both groups. During follow-up period (mean 44±32 months), 82 patients died (22 cardiac) in the PCI group and 54 patients died (22 cardiac) in the medication group. Eight-year Kaplan-Meier survival rate for cardiac and all-cause mortality were significantly higher in the PCI group than in the medication group (87.3% vs. 71.2% and 52.4% vs. 31.0%, both p < 0.0001). After the propensity score matching, 187 patients treated with PCI and 109 patients treated with medication alone were matched. Still, cardiac and all-cause survival rate were higher in the PCI group than in the medication group (83.3% vs. 70.6%, p = 0.0004 and 47.8% vs. 31.3%, p = 0.0008). On multivariate Cox analysis, PCI was an independent predictor of better survival for cardiac mortality [HR 0.35, 95% confidential interval (CI) 0.19-0.67, p = 0.0019] and all-cause mortality (HR 0.54, 95%CI 0.33-0.87, p = 0.012).

Conclusion: These data suggest that PCI has more beneficial effect on clinical outcome including both cardiac and all-cause survival compared to medication alone in HD patients even with SVD.

  • Intervention
  • Hemodynamics
  • Percutaneous coronary intervention
  • © 2011 by American Heart Association, Inc.
Back to top
Previous Article

This Issue

Circulation
22 November 2011, Volume 124, Issue Suppl 21
  • Table of Contents
Previous Article

Jump to

  • Article
  • Info & Metrics

Article Tools

  • Citation Tools
    Abstract 12514: Percutaneous Coronary Intervention is Beneficial For Better Survival Compared With Medication Alone in Chronic Hemodialysis Patients With Single-Vessel Disease
    Takashi Sakakibara, Hideki Ishii, Kouhei Yoneda, Kazuhiro Kawashima, Yoshihiro Kawamura, Daisuke Kamoi, Toru Aoyama, Kyuuichi Furuhashi, Yoshitake Kumada, Hiroshi Takahashi, Miho Tanaka and Toyoaki Murohara
    Circulation. 2011;124:A12514, originally published December 23, 2015

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Abstract 12514: Percutaneous Coronary Intervention is Beneficial For Better Survival Compared With Medication Alone in Chronic Hemodialysis Patients With Single-Vessel Disease
    (Your Name) has sent you a message from Circulation
    (Your Name) thought you would like to see the Circulation web site.
  • Share on Social Media
    Abstract 12514: Percutaneous Coronary Intervention is Beneficial For Better Survival Compared With Medication Alone in Chronic Hemodialysis Patients With Single-Vessel Disease
    Takashi Sakakibara, Hideki Ishii, Kouhei Yoneda, Kazuhiro Kawashima, Yoshihiro Kawamura, Daisuke Kamoi, Toru Aoyama, Kyuuichi Furuhashi, Yoshitake Kumada, Hiroshi Takahashi, Miho Tanaka and Toyoaki Murohara
    Circulation. 2011;124:A12514, originally published December 23, 2015
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Circulation

  • About Circulation
  • Instructions for Authors
  • Circulation CME
  • Statements and Guidelines
  • Meeting Abstracts
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
200 Fifth Avenue, Suite 1020
Waltham, MA 02451
email: circ@circulationjournal.org
 

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured